EssilorLuxottica has been named in the ‘Time100 Most Influential Companies’ list for 2025 in the category of ‘Innovators’.

An eight-year clinical study has provided strong evidence that defocus incorporated multiple segments (DIMS) technology continues to significantly reduce myopia progression and axial elongation

Revised state-wide glaucoma referral criteria have been issued in Victoria.

Prominent New Zealand ophthalmologist Dr Aparna Raniga is promising to “reframe the narrative” for optometrists who feel like their role in glaucoma care sits